Skip to content

Safety and Efficacy of Body Lotion and Body Wash in Adult Female Subjects with Mild To Moderate Eczema.

An Open-label, Single Centre Study, to Determine the Safety and Efficacy of Body Lotion and Body Wash in Adult Female Subjects with Mild To Moderate Eczema.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/03/032149
Enrollment
20
Registered
2021-03-19
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L208- Other atopic dermatitis

Interventions

Intervention1: Body Lotion: Subjects will be instructed to apply pea�sized amount of test product twice a day for each eczema site on their body to moisturize the test skin site Intervention2: Bo

Sponsors

Wipro Manufacturing Services Sdn Bhd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age: 18 to 65 years (both inclusive) old healthy, non-pregnant, and non-lactating female at the time of consent. 2. Females who have childbearing potential should have a negative urine pregnancy test at the time of the screening visit. 3. Mild to Moderate Eczema determined by Eczema Area and Severity Index (EASI) score on screening visit. [Subjects with moderate erythema (Redness: score 2) and mild scratch mark (Scratching: score 1) will be enrolled in the study]. 4. Subjects with at least two active lesions on feet/face/hands or any part of the body. 5. Subjects have only a few or no pigmentation on the selected test site. 6. The subjectââ?¬•s in general good health as determined by Investigator based on medical history. 7. Subjects must agree to refrain from shower/bath or generally wet their skin within 3 hours before scheduled study visits. 8. Subjects must agree to wear loose clothing to allow easy exposure to the entire body during study visits. 9. Subjects must be able to understand and provide written informed consent to participate in the study. 10. Subjects should be willing and able to follow the study protocol to participate in the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
1. Selection of unaffected and affected test sites by the dermatologist using instrument evaluations. 2. Calculation of eczema area by dermatologist using Eczema Area and Severity Index (EASI). Timepoint: 1. On Day 01 before application and on Day 14 and Day 28 after product usage 2. On Day 01 before application and Day 14 and Day 28 after product usage

Secondary

MeasureTime frame
1. cutaneous tolerance/ local irritation i.e. Erythema, Oedema, Dryness, Flaking, Scaling, Itching, Peeling, Pigmentation for body wash and body lotion 2. Global Assessment Scale (IGA) for body wash and body lotion 3. itchiness of skin using Itch NRS scale for body lotion 4. subjective self-assessment i.e. perceived symptoms of irritation such as Burning, Itching, and Stinging for body wash and body lotion 5. subjective perception about product for body wash and body lotion Timepoint: 1. On Day 01, Day 14 and Day 28 2. On Day 01, Day 14 and Day 28 3. Day 01 i.e. Baseline, 0 sec before application, to 10 sec, 20 sec, 30 sec, 40 sec, 50 sec, 60 sec, 2 min, 5 min, 10 min and 15 min after application on Day 01. 4. On Day 01, Day 14 and Day 28 5. On Day 14 and Day 28

Countries

India

Contacts

Public ContactDr Simran Sethi

Cliantha Research

pjoshi@cliantha.com8000085049

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026